美国NDC复合药物数据库文件

药品名称：商品名称：药品NDC：报告期内： -格式:2020-5-3
NDC包装id：市场分类：活性成分：持证企业：

美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)

药品名称(分析)

商品名

药品NDC

专利人(分析)

报告期内

活性成分

市场分类

规格(分析)

NDC包装id

Fentanyl Citrate

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 ug/1 mL

73177-102-27

Lidocaine Hydrochloride

HUMAN COMPOUNDED DRUG

71506-043

Fresenius Kabi Compounding LLC DBA Fagron Sterile Services

2024-1

LIDOCAINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL

71506-043-01

Atropine Sulfate

HUMAN COMPOUNDED DRUG

71506-036

Fresenius Kabi Compounding LLC DBA Fagron Sterile Services

2024-1

ATROPINE SULFATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.4 mg/1 mL

71506-036-01

Ephedrine Sulfate

HUMAN COMPOUNDED DRUG

71506-022

Fresenius Kabi Compounding LLC DBA Fagron Sterile Services

2024-1

EPHEDRINE SULFATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

15 mg/3 mL

71506-022-35

Epinephrine

HUMAN COMPOUNDED DRUG

71506-060

Fresenius Kabi Compounding LLC DBA Fagron Sterile Services

2024-1

EPINEPHRINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

8 mg/250 mL

71506-060-58

Thiamine Hydrochloride

HUMAN COMPOUNDED DRUG

71506-079

Fresenius Kabi Compounding LLC DBA Fagron Sterile Services

2024-1

THIAMINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

500 mg/100 mL

71506-079-56

Epinephrine

HUMAN COMPOUNDED DRUG

83298-305

Mark Cuban Cost Plus Manufacturing and Compounding LLC

2024-1

EPINEPHRINE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

5 mg/5 mL

83298-305-07

Bupivacaine with Epinephrine

HUMAN COMPOUNDED DRUG

83298-339

Mark Cuban Cost Plus Manufacturing and Compounding LLC

2024-1

EPINEPHRINE; BUPIVACAINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.05 mg/10 mL; 25 mg/10 mL

83298-339-10

Prednisolone Phosphate 1%, Moxifloxacin 0.5%, Bromfenac 0.075%

HUMAN COMPOUNDED DRUG

83826-9016

OSRX, Inc.

2024-1

MOXIFLOXACIN HYDROCHLORIDE; PREDNISOLONE SODIUM PHOSPHATE; BROMFENAC SODIUM

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL

83826-9016-8

Timolol 0.5, Brimonidine Tartrate 0.1, Dorzolamide 2, Bimatoprost 0.01

HUMAN COMPOUNDED DRUG

83826-9003

OSRX, Inc.

2024-1

BIMATOPROST; TIMOLOL MALEATE; DORZOLAMIDE HYDROCHLORIDE; BRIMONIDINE TARTRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.1 mg/1 mL; 5 mg/1 mL; 20 mg/1 mL; 1 mg/1 mL

83826-9003-5

Timolol 0.5%, Brimonidine Tartrate 0.1%, Dorzolamide 2%

HUMAN COMPOUNDED DRUG

83826-9006

OSRX, Inc.

2024-1

TIMOLOL MALEATE; BRIMONIDINE TARTRATE; DORZOLAMIDE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

5 mg/1 mL; 1 mg/1 mL; 20 mg/1 mL

83826-9006-5

Atropine Sulfate Monohydrate 0.01%

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.1 mg/1 mL

83826-9010-3

Atropine Sulfate Monohydrate 0.025%

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.25 mg/1 mL

83826-9011-3

Timolol 0.5%, Bimatoprost 0.01%

HUMAN COMPOUNDED DRUG

83826-9018

OSRX, Inc.

2024-1

BIMATOPROST; TIMOLOL MALEATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.1 mg/1 mL; 5 mg/1 mL

83826-9018-5

Tropicamide 1%, Cyclopentolate 1%, Phenylephrine 2.5%

HUMAN COMPOUNDED DRUG

71266-8211

Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories

2024-1

PHENYLEPHRINE HYDROCHLORIDE; CYCLOPENTOLATE HYDROCHLORIDE; TROPICAMIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL

71266-8211-5

Phenylephrine HCl

HUMAN COMPOUNDED DRUG

71266-9022

Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories

2024-1

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.1 mg/1 mL

71266-9022-1

Betamethasone Sodium Phosphate

HUMAN COMPOUNDED DRUG

71266-1025

Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories

2024-1

BETAMETHASONE SODIUM PHOSPHATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

6 mg/1 mL

71266-1025-1

Betamethasone Sodium Phosphate

HUMAN COMPOUNDED DRUG

71266-1025

Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories

2024-1

BETAMETHASONE SODIUM PHOSPHATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

6 mg/1 mL

71266-1025-2

Sodium Citrate

HUMAN COMPOUNDED DRUG

71266-6641

Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories

2024-1

TRISODIUM CITRATE DIHYDRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

40 mg/1 mL

71266-6641-1

Phenol in Water

HUMAN COMPOUNDED DRUG

71266-6519

Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories

2024-1

PHENOL

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

60 mg/1 mL

71266-6519-1

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：